Showing results (41-50 of 234) with videos related to
Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliatesCharlie C Pan, Julia S Lee, June L Chan, et al.International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trialKevin S Oh, Daniel E Soto, David C Smith, et al.Journal of Neuro-Oncology|May 9, 2002
Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumorsDonald A Ross, Howard M Sandler, James M Balter, et al.International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202Mingxin Che, Michelle DeSilvio, Alan Pollack, et al.Urology|March 4, 2008
Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413Daniel Taussky, Kyounghwa Bae, Jean-Paul Bahary, et al.Journal of the National Cancer Institute|February 13, 2009
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trialMichael E Ray, Kyounghwa Bae, Maha H A Hussain, et al.International Journal of Radiation Oncology, Biology, Physics|May 23, 2008
Predicting biochemical failure and overall survival through intratherapy PSA changes during definitive external beam radiotherapyDaniel E Soto, Rebecca R Andridge, Jeremy M G Taylor, et al.International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?Richard K Valicenti, Kathryn Winter, James D Cox, et al.International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
In patients experiencing biochemical failure after radiotherapy, pretreatment risk group and PSA velocity predict differences in overall survival and biochemical failure-free intervalDaniel E Soto, Rebecca R Andridge, Charlie C Pan, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2008
Determining if pretreatment PSA doubling time predicts PSA trajectories after radiation therapy for localized prostate cancerDaniel E Soto, Rebecca R Andridge, Charlie C Pan, et al.Pageof 24